Leonteq Securities AG’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Sell
400,000
-200,000
-33% -$5.32M 0.42% 50
2025
Q4
$14.9M Buy
600,000
+200,000
+50% +$5.04M 0.46% 36
2025
Q3
$10.2M Buy
+400,000
New +$9.87M 0.31% 58
2024
Q3
Sell
-100,000
Closed -$2.8M 1256
2024
Q2
$2.8M Buy
+100,000
New +$2.75M 0.2% 94
2024
Q1
Sell
-1,100
Closed -$31.7K 1257
2023
Q4
$31.7K Buy
+1,100
New +$33.3K ﹤0.01% 862

Other funds holding PFE

Leonteq Securities AG's PFE Position: Q1 2026 in Review

Leonteq Securities AG reduced its Pfizer (PFE) stake by 84% in Q1 2026, selling an estimated $16.9M and leaving 122,401 shares worth $3.44M. The position accounts for 0.13% of the portfolio, ranked #131.

Leonteq Securities AG first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $26.2M in Q2 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Leonteq Securities AG held 122,401 shares of Pfizer worth $3.44M as of Q1 2026.
  • Leonteq Securities AG sold 633,016 Pfizer shares in Q1 2026, an estimated $16.9M.
  • Pfizer made up 0.13% of Leonteq Securities AG's portfolio in Q1 2026, its #131 holding.
  • Leonteq Securities AG first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Leonteq Securities AG's Pfizer position peaked at $26.2M in Q2 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.